Patent Assignment
Reel/Frame 017083/0008
Merger & Change of Name
Recorded: 2005-12-13
Pages: 38
Assignor
YAMANOUCHI PHARMACEUTICAL CO., LTD.
Executed: 2005-04-01
Assignee
ASTELLAS PHARMA INC.
3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, 103-8411, JAPAN
Covered Properties
(54)
Polycyclic Pyridines as Potassium Ion Channel Modulators
PCT:
PCT/US2005/012837 ↗
Colon Specific Drug Release System
Patent:
6,368,629 →
Application:
09/183,339 →
Sustained Release Medicinal Compositions
Patent:
6,328,979 →
Application:
09/582,384 →
Sustained Release Pharmaceutical Compositions
Patent:
6,919,372 →
Application:
09/582,404 →
Stable Pharmaceutical Composition for Oral Use
Patent:
6,562,375 →
Application:
09/629,405 →
Tablets Quickly Disintegrating in the Oral Cavity and Process for Producing the Same
Patent:
6,589,554 →
Application:
09/646,249 →
Timed-Release Compression-Coated Solid Composition for Oral Administration
Application:
09/834,410 →
Publication:
US 2002/0028240
Drug Delivery System for Averting Pharmacokinetic Drug Interaction and Method Thereof
Quick Disintegrating Tablet in Buccal Cavity and Manufacturing Method Thereof
Pharmaceutical Composition for Oral Use with Improved Absorption
Colon-Specific Drug Release System
Quick-Disintegrating Tablet in Buccal Cavity and Manufacturing Method Thereof
Composition Comprises Sustained-Release Fine Particles and Manufacturing Method Thereof
Pharmaceutical Composition for Oral Use with Improved Absorption
Novel dry powder inhalation for lung-delivery and manufacturing method thereof
Application:
10/393,766 →
Publication:
US 2004/0184995
Quick Disintegrating Tablet in Buccal Cavity and Manufacturing Method Thereof
Method for Improving Adsorption of a Drug from Ethylene Oxide Derivative
Immune response induction method
Application:
10/674,581 →
Publication:
US 2005/0031587
Pharmaceutical Composition for Controlled Release of Active Substances and Manufacturing Method Thereof
Lipid-Peptide-Polymer Conjugates for Long Blood Circulation and Tumor Specific Drug Delivery Systems
Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
Application:
10/766,201 →
Publication:
US 2004/0253309
Sustained Release Pharmaceutical Composition
Sustained Release Pharmaceutical Composition
Drug delivery system for averting pharmacokinetic drug interaction and method thereof
Application:
10/866,524 →
Publication:
US 2005/0163840
Pharmaceutical Composition for Oral Use with Improved Absorption
Coated fine particles containing drug for intrabuccally fast disintegrating tablet
Application:
10/975,210 →
Publication:
US 2005/0175689
Quick disintegrating tablet in buccal cavity and manufacturing method thereof
Application:
11/009,644 →
Publication:
US 2005/0100599
Polycyclic thiazoles as potassium ion channel modulators
Application:
11/105,665 →
Publication:
US 2005/0227989
Polycyclic Pyrazines as Potassium Ion Channel Modulators
Polycyclic Pyrimidines as Potassium Ion Channel Modulators
Oral Pharmaceutical Compositions in Timed-Release Particle Form and Fast-Disintegrating Tablets Containing This Composition
Oral Pharmaceutical Composition for Improved Light Stability and Method Thereof
Application:
60/147,222 →
Drug delivery system for reducing pharmacokinetic drug-interaction and method thereof
Application:
60/197,574 →
Oral pharmaceutical compositions for reducing drug-interaction in pharmacotherapy and method thereof
Application:
60/198,086 →
Quick disintegrating tablet in vaccal cavity and manufacturing method thereof
Application:
60/215,292 →
Pharmaceutical composition for oral use with improved absorption
Application:
60/218,980 →
Quick disintegrating tablet and manufacturing method thereof
Application:
60/290,300 →
Composition comprises sustained-release fine particles and manufacturing method thereof
Application:
60/308,303 →
Pharmaceutical composition for oral use with improved absorption
Application:
60/349,784 →
Novel dry powder inhalation for lung-delivery and manufacturing method thereof
Application:
60/365,697 →
Dry powder inhalation formulation for sustained-release and manufacturing method thereof
Application:
60/365,752 →
Use of polyethylene oxide derivatives for drug delivery
Application:
60/414,313 →
Induction method of immune response
Application:
60/415,026 →
Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems
Application:
60/439,560 →
Enteric sustained-released fine particles of tamsulosin or its salt and manufacturing method thereof
Application:
60/442,984 →
Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
Application:
60/453,046 →
Coated fine particles containing drug for intrabuccally fast disintegrating tablet
Application:
60/515,070 →
Pyrimidinyl amines as potassium ion channel modulators
Application:
60/561,990 →
Thiazolyl amines as potassium ion channel modulators
Application:
60/562,019 →
Pyridinyl amines as potassium ion channel modulators
Application:
60/562,035 →
Pyrazinyl as potassium ion channel modulators
Application:
60/562,149 →
Oral pharmaceutical compositions of timed-release particles and tablets quickly disintegrable in the oral cavity containing compositions thereof
Application:
60/567,301 →
Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
Application:
60/701,139 →
Nanoparticles of poorly-soluble drug having enteric polymer adsorbed on the surface thereof
Application:
60/714,924 →
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 23, 2000
From: YAMASHITA, NOBORU; TAKAGI, AKIRA; KATSUMA, MASATAKA; SAITO, KATSUMI
To: YAMANOUCHI PHARMACEUTICALS, CO. LTD.
Reel/Frame 010982/0465 →
Assignment of Assignor's Interest
Jun 23, 2000
From: YAMASHITA, NOBORU; TAKAGI, AKIRA; KATSUMA, MASATAKA; SAITO, KATSUMI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.; TORAY INDUSTRIES, INC.
Reel/Frame 010991/0724 →
Assignment of Assignor's Interest
Nov 13, 2000
From: SAKO, KAZUHIRO; SAWADA, TOYOHIRO; YOSHIHARA, KEIICHI; YOSHIOKA, TATSUNOBU
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 011247/0374 →
Assignment of Assignor's Interest
Nov 27, 2000
From: MIZUMOTO, TAKAO; MASUDA, YOSHINORI; KAJIYAMA, ATSUSHI; YANGISAWA, MASAHIRO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.; YAMANOUCHI PHARMA TECHNOLOGIES, INC.
Reel/Frame 011335/0253 →
Assignment of Assignor's Interest
Oct 1, 2001
From: SAWADA, TOYOHIRO; SAKO, KAZUHIRO; YOSHIOKA, TATSUNOBU; WATANABE, SHUNSUKE
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 012222/0479 →
Assignment of Assignor's Interest
Jan 7, 2002
From: KAJIYAMA, ATUSHI; TAMURA, TETSUYA; MIZUMOTO, TAKAO; KAWAI, HITOSHI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 012448/0458 →
Assignment of Assignor's Interest
Jan 9, 2002
From: SAWADA, TOYOHIRO; SAKO, KAZUHIRO; YOSHIOKA, YATSUNOBU; WATANABE, SHUNSUKE
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 012467/0198 →
Assignment of Assignor's Interest
Jan 10, 2002
From: WATANABE, SHUNSUKE; TAKEMURA, SHIGEO; TSUTSUI, YUUKI; KONDO, HIROMU
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 012468/0983 →
Assignment of Assignor's Interest
Nov 27, 2002
From: SHINODA, TATSUKI; MAEDA, ATSUSHI; ITOU, NAOKI; MIZUMOTO, TAKAO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 013555/0284 →
Assignment of Assignor's Interest
Dec 2, 2002
From: TAKAISHI, YUUKI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 013539/0502 →
Assignment of Assignor's Interest
May 12, 2003
From: WATANABE, SHUNSUKE; NAKANISHI, KIYO; TAKEMURA, SHIGEO; TSUTSUI, YUUKI
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 014053/0025 →
Assignment of Assignor's Interest
Sep 8, 2003
From: KATSUMA, MASATAKA; KAWAI, HITOSHI; MIZUMOTO, TAKAO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 014459/0016 →
Assignment of Assignor's Interest
Jun 9, 2004
From: SUGIHARA, AKIO; SAKO, KAZUHIRO; SAWADA, TOYOHIRO
To: YAMANOUCHI PHARMACEUCTICAL CO., LTD.
Reel/Frame 014714/0532 →
Assignment of Assignor's Interest
Aug 26, 2004
From: ATSUSHI, MAEDA; TAKAGI, AKIRA; SAITO, KATSUMI; YAMASHITA, NOBORU
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 015088/0350 →
Assignment of Assignor's Interest
Sep 2, 2004
From: TSUTSUI, YUUKI; NAKANISHI, KIYO; WATANABE, SHUNSUKE; TAKEMURA, SHIGEO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 015103/0791 →
Assignment of Assignor's Interest
Sep 12, 2007
From: WANG, XIAODONG; SPEAR, KERRY L.; FULP, ALAN B.; SECONI, DARRICK
To: ICAGEN, INC.
Reel/Frame 019815/0264 →
Assignment of Assignor's Interest
Sep 12, 2007
From: SUZUKI, TAKESHI; ISHII, TAKAHIRO; MORITOMO, AYAKO; KUBOTA, HIDEKI
To: ASTELLAS PHARMA INC.
Reel/Frame 019815/0214 →
Corrective Assignment to Correct the Dates of Execution by Inventors. Document Previously Recorded at Reel 019815 Frame 0214.
Dec 21, 2007
From: SUZUKI, TAKESHI; ISHII, TAKAHIRO; MORITOMO, AYAKO; KUBOTA, HIDEKI
To: ASTELLAS PHARMA INC.
Reel/Frame 020293/0213 →
Assignment of Assignor's Interest
Jul 8, 2010
From: YOSHIHARA, KEIICHI; SAKO, KAZUHIRO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 024651/0455 →
Assignment of Assignor's Interest
May 30, 2014
From: ASTELLAS PHARMA US, INC.
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 032994/0603 →
Assignment of Assignor's Interest
Apr 17, 2015
From: ASTELLAS IRELAND CO., LTD.
To: ASTELLAS PHARMA US, INC.
Reel/Frame 035437/0972 →
Assignment of Assignor's Interest
Apr 17, 2015
From: ASTELLAS PHARMA INC.
To: ASTELLAS IRELAND CO., LTD.
Reel/Frame 035437/0401 →